EUVIMEDEUVIMED entdecken
Crossref

Hemophagocytic lymphohistiocytosis in 60 Mexican children with chronic granulomatous disease

Alix Sherlyn Monroy-García iD, Tiareth Lisset Cova-Guzmán iD, Ana Luisa Rodriguez Lozano iD, Francisco Rivas-Larrauri, Selma Scheffler-Mendoza iD, Melissa Espinosa-Navarro, Juan Carlos Bustamante-Ogando, Yuridia Salazar-Galvéz, Cesar Mauricio Rojas-Maruri iD, Celso Tomas Corcuera-Delgado, Isabel Medina-Vera iD, Sara Espinosa-Padilla iD und 2 weitere

Pediatric Allergy and Immunology · 2025-11 · 36 (11)

DOI: 10.1111/pai.70234 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Allergy and Immunology, online erschienen am 01.11.2025. Verfasst von Alix Sherlyn Monroy-García und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Immunology, National Institute of Pediatrics, Mexico City, Mexico. Hauptthemen laut MEDLINE: Lymphohistiocytosis, Hemophagocytic, Granulomatous Disease, Chronic, COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with chronic granulomatous disease (CGD) can develop hemophagocytic lymphohistiocytosis (HLH), exacerbating mortality risk. Despite its clinical significance, data on HLH in CGD from international cohorts remain limited. This study aims to describe the occurrence of HLH in a cohort of patients with CGD, providing clinical insight into this association and emphasizing the need for early recognition and effective management.

Methods

The records of 60 patients with CGD were reviewed. Those meeting the diagnostic criteria for HLH based on the HScore were included in the analysis. Both descriptive and inferential statistics were employed to evaluate the data.

Results

Eleven patients (18.3%) fulfilled the HLH diagnostic criteria. The median interval between CGD genetic diagnosis and HLH onset was 36 months, with a median age at HLH diagnosis of 67 months. Infectious triggers were identified in eight cases, with Salmonella and Aspergillus species being the most common. One case involved an inflammatory trigger—multisystem inflammatory syndrome in children (MIS‐C) following SARS‐CoV‐2 infection. Mortality was high: 72.7% of the patients with HLH died. No significant difference ( p = .338) was observed between those who died after receiving only immunosuppressive therapy ( n = 2) and those who received both intravenous immunoglobulin and immunosuppressive therapy ( n = 6).

Conclusion

HLH in CGD is associated with a high mortality rate. Notably, MIS‐C can present as an inflammatory trigger for HLH in this population. Careful evaluation of HLH parameters is recommended for all patients with CGD admitted with infection or inflammation to facilitate early diagnosis and guide management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphohistiocytosis, HemophagocyticGranulomatous Disease, ChronicCOVID-19HumansMaleFemaleChild, PreschoolMexicoChildInfantRetrospective StudiesAdolescentSARS-CoV-2

Stichwörter der Autor:innen

COVID 19SARS‐CoV2chronic granulomatous diseasehemophagocytic lymphohistiocytosisinborn errors of immunitymacrophage activation syndromemultisystem inflammatory syndrome in childrenprimary immunodeficiency

Autor:innen und Institutionen

  • Department of Clinical Immunology, National Institute of Pediatrics, Mexico City, Mexico.
  • Laboratory of Immunodeficiency, National Institute of Pediatrics, Mexico City, Mexico.
  • Department of Clinical Immunology, UMAE #25, IMSS, Monterrey, Nuevo León, Mexico.
  • Surgical Pathology Service, National Institute of Pediatrics, Mexico City, Mexico.
  • Department of Research Methodology, National Institute of Pediatrics, Mexico City, Mexico.

ORCID-Profile: Alix Sherlyn Monroy-García, Tiareth Lisset Cova-Guzmán, Ana Luisa Rodriguez Lozano, Selma Scheffler-Mendoza, Cesar Mauricio Rojas-Maruri, Isabel Medina-Vera, Sara Espinosa-Padilla, Marco Antonio Yamazaki-Nakashimada, Lizbeth Blancas-Galicia

Zitieren

APA

Monroy-García, A. S., Cova-Guzmán, T. L., Rodriguez Lozano, A. L., Rivas-Larrauri, F., Scheffler-Mendoza, S., Espinosa-Navarro, M., Bustamante-Ogando, J. C., Salazar-Galvéz, Y., Rojas-Maruri, C. M., Corcuera-Delgado, C. T., Medina-Vera, I., Espinosa-Padilla, S., Yamazaki-Nakashimada, M. A., & Blancas-Galicia, L. (2025). Hemophagocytic lymphohistiocytosis in 60 Mexican children with chronic granulomatous disease. Pediatric Allergy and Immunology, 36(11). https://doi.org/10.1111/pai.70234

Vancouver

Monroy-García AS, Cova-Guzmán TL, Rodriguez Lozano AL, Rivas-Larrauri F, Scheffler-Mendoza S, Espinosa-Navarro M, et al. Hemophagocytic lymphohistiocytosis in 60 Mexican children with chronic granulomatous disease. Pediatric Allergy and Immunology. 2025;36(11). doi:10.1111/pai.70234

BibTeX
@article{MonroyGarca2025,
  author = {Monroy-García, Alix Sherlyn and Cova-Guzmán, Tiareth Lisset and Rodriguez Lozano, Ana Luisa and Rivas-Larrauri, Francisco and Scheffler-Mendoza, Selma and Espinosa-Navarro, Melissa and Bustamante-Ogando, Juan Carlos and Salazar-Galvéz, Yuridia and Rojas-Maruri, Cesar Mauricio and Corcuera-Delgado, Celso Tomas and Medina-Vera, Isabel and Espinosa-Padilla, Sara and Yamazaki-Nakashimada, Marco Antonio and Blancas-Galicia, Lizbeth},
  title = {Hemophagocytic lymphohistiocytosis in 60 Mexican children with chronic granulomatous disease},
  journal = {Pediatric Allergy and Immunology},
  year = {2025},
  volume = {36},
  number = {11},
  doi = {10.1111/pai.70234}
}
Kostenlos starten →